Sources | Names Used |
---|---|
CCLE, GDSC1000, GRAY, FIMM | Sorafenib |
CTRPv2 | sorafenib |
PharmacoGx | Sorafenib |
Database | Identifier |
---|---|
Smiles: | CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F |
Inchikey: | MLDQJTXFUGDVEO-UHFFFAOYSA-N |
Pubchem: | 216239 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WDR49 | CCLE | pan-cancer | AAC | 0.32 | 2e-12 |
mRNA | LPAR4 | CCLE | pan-cancer | AAC | 0.33 | 2e-12 |
mRNA | APOBR | CCLE | pan-cancer | AAC | 0.35 | 3e-12 |
mRNA | LST1 | CCLE | pan-cancer | AAC | 0.38 | 3e-12 |
mRNA | CIB3 | GDSC1000 | pan-cancer | AAC | 0.37 | 4e-12 |
mRNA | CLEC12A | CCLE | pan-cancer | AAC | 0.32 | 5e-12 |
mRNA | CD300LF | GDSC1000 | pan-cancer | AAC | 0.37 | 5e-12 |
mRNA | P2RX1 | CCLE | pan-cancer | AAC | 0.38 | 6e-12 |
mRNA | AOAH | CCLE | pan-cancer | AAC | 0.31 | 8e-12 |
mRNA | LAIR1 | CCLE | pan-cancer | AAC | 0.4 | 9e-12 |